Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07824206
PHASE4

Lumateperone Added to Antidepressant Therapy in Adults With Major Depressive Disorder Experiencing Emotional Blunting

Sponsor: Future Options Research, LLC

View on ClinicalTrials.gov

Summary

The purpose of this study is to evaluate whether or not adding lumateparone to current antidepressant treatment in adults with major depressive disorder experiencing blunted emotion will reduce or eliminate the blunted emotion as rated by the Oxford Depression Questionnaire.

Key Details

Gender

All

Age Range

18 Years - 75 Years

Study Type

INTERVENTIONAL

Enrollment

30

Start Date

2026-09

Completion Date

2028-03

Last Updated

2026-09-17

Healthy Volunteers

No

Interventions

DRUG

lumateparone 42 mg once daily

lumateparone 42 mg once daily added to current antidepressant treatment

DRUG

lumateparone

Lumateparone

Locations (1)

Future Options Research

State College, Pennsylvania, United States